Clinical Trial Detail

NCT ID NCT01459211
Title Pilot Study to Establish Safety and Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications

chronic lymphocytic leukemia

Therapies

Dexamethasone

Lenalidomide

Age Groups: adult

No variant requirements are available.